SYNBIOTIC COMPOSITIONS Russian patent published in 2023 - IPC A61K35/742 A61K31/198 A61K38/05 A23K10/18 A23K20/142 A23K20/147 A23K20/174 A23K20/20 A23L33/135 A23L33/175 A23L33/18 

FIELD: pharmaceuticals; food industry.

SUBSTANCE: synbiotic preparation containing at least one probiotic strain selected from Bacillus subtilis DSM 32315, Bacillus subtilis DSM 32540, Bacillus licheniformis DSM 32314, Bacillus amyloliquefaciens CECT 5940, and at least one amino acid selected from glutamine, glutamic acid or its salts, conjugated glutamine or oligopeptides with a length of 2–10 amino acid structural units, while these amino acid structural units are natural amino acids, and at least one amino acid structural unit is a unit representing glutamine or glutamic acid, and the total amount of the probiotic strain and amino acid or oligopeptide is at least 40 wt.% are proposed. Also the use of a synbiotic drug as a feed or food additive, as a synbiotic ingredient in feed or food products, a feed or food composition containing the specified drug, a pharmaceutical composition containing the specified drug, the use of this pharmaceutical composition in the prevention or treatment of various diseases, capsule with a synbiotic drug are proposed.

EFFECT: proposed synbiotic drug contributes to the generation of taxa producing n-butyrate, and an increase in the level of n-butyrate in the intestine.

18 cl, 10 dwg, 3 tbl, 13 ex